Publications

Recent Publications

  1. Rawizza HE, Chaplin B, Meloni ST, Darin KM, Olaitan O, Scarsi KK, Onwuamah CK, Audu RA, Chebu PR, Imade GE, Okonkwo P, Kanki PJ. Accumulation of protease mutations among patients failing second-line antiretroviral therapy and response to salvage therapy in Nigeria. PLoS One. 2013 Sep 17;8(9):e73582. eCollection 2013. PMID: 24069209; PMCID: PMC3775797.
  2. Agbaji O, Thio CL, Meloni S, Graham C, Muazu M, Nimzing L, Idoko J, Sankalé JL, Ekong E, Murphy R, Kanki P, Hawkins C. Impact of hepatitis C virus on HIV response to antiretroviral therapy in Nigeria. J Acquir Immune Defic Syndr. 2013 Feb 1;62(2):204-7. PMID: 2319683; PMCID: PMC3548937.
  3. Falade CO, Adesina-Adewole B, Dada-Adegbola HO, Ajayi IO, Akinyemi JO, Ademowo OG, Adewole IF, Kanki P. Evaluation of Paracheck-Pf(TM) rapid malaria diagnostic test for the diagnosis of malaria among HIV-positive patients in Ibadan, south-western Nigeria. Pathog Glob Health. 2013 Mar;107(2):69-77. PMID: 23683333; PMCID: PMC4001481.
  4. Ladep NG, Agaba PA, Agbaji O, Muazu A, Ugoagwu P, Imade G, Cooke G, McCormack S, Taylor-Robinson SD, Idoko J, Kanki P. Rates and impact of hepatitis on human immunodeficiency virus infection in a large African cohort. World J Gastroenterol. 2013 Mar 14;19(10):1602-10. PMID: 23538773; PMCID: PMC3602477.
  5. Dinic L, Idigbe OE, Meloni S, Rawizza H, Akande P, Eisen G, Onwujekwe D, Agbaji O, Ani A, Kanki PJ. Sputum smear concentration may misidentify acid-fast bacilli as Mycobacterium tuberculosis in HIV-infected patients. J Acquir Immune Defic Syndr. 2013 Jun 1;63(2):168-77. PMID: 23392466.
  6. Akanbi MO, Achenbach CJ, Feinglass J, Taiwo B, Onu A, Pho MT, Agbaji O, Kanki P, Murphy RL. Tuberculosis after one year of combination antiretroviral therapy in Nigeria: a retrospective cohort study. AIDS Res Hum Retroviruses. 2013 Jun;29(6):931-7. Epub 2013 Feb 25. PMID: 23316724; PMCID: PMC3653369.
  7. Tang MW, Rhee SY, Bertagnolio S, Ford N, Holmes S, Sigaloff KC, Hamers RL, de Wit TF, Fleury HJ, Kanki PJ, Ruxrungtham K, Hawkins CA, Wallis CL, Stevens W, van Zyl GU, Manosuthi W, Hosseinipour MC, Ngo-Giang-Huong N, Belec L, Peeters M, Aghokeng A, Bunupuradah T, Burda S, Cane P, Cappelli G, Charpentier C, Dagnra AY, Deshpande AK, El-Katib Z, Eshleman SH, Fokam J, Gody JC, Katzenstein D, Koyalta DD, Kumwenda JJ, Lallemant M, Lynen L, Marconi VC, Margot NA, Moussa S, Ndung’u T, Nyambi PN, Orrell C, Schapiro JM, Schuurman R, Sirivichayakul S, Smith D, Zolfo M, Jordan MR, Shafer RW. Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine. J Infect Dis. 2013 Jun 15;207 Suppl 2:S70-7. PMID: 23687292;   PMCID: PMC3657117.
  8. Ladep NG, Agbaji OO, Agaba PA, Muazu A, Ugoagwu P, Imade G, Cooke GS, Vivas L, Cormack SM, Taylor-Robinson SD, Idoko J, Kanki P. Hepatitis B Co-Infection is Associated with Poorer Survival of HIV-Infected Patients on Highly Active Antiretroviral Therapy in West Africa. J AIDS Clin Res. 2013 Jun 29;Suppl 3. PMID: 25328814; PMCID: PMC4199237.
  9. Agbaji O, Ebonyi AO, Meloni ST, Anejo-Okopi JA, Akanbi MO, Oguche S, Agaba PA, Sagay AS, Okonkwo P, Kanki P. Factors associated with pulmonary tuberculosis-HIV co-infection in treatment naive adults in Jos, North Central Nigeria. Journal of AIDS & Clinical Research. 2013 July; 4(7):1-5.
  10. Imade GE, Sagay AS, Musa J, Ocheke AN, Adeniyi DS, Idighri M, Powl R, Sendeht A, Ogwuche JP, Elujoba M, Egbodo CO, Oyebode T, Daru PH, Agbaji O, Pam IC, Meloni ST, Okonkwo P, Kanki PJ. Declining rate of infection with maternal human immunodeficiency virus at delivery units in north-central Nigeria. Afr J Reprod Health. 2013 Dec;17(4 Spec No):138-45. PMID: 24689325.
  11. Musa J, Taiwo B, Achenbach C, Olugbenga S, Berzins B, Sagay AS, Idoko JA, Kanki PJ, Murphy RL. High-risk human papillomavirus among HIV-infected women with normal cervical cytology: a pilot study in Jos, Nigeria. Arch Gynecol Obstet. 2013 Dec;288(6):1365-70. Epub 2013 May 23. PMID: 23700253.
  12. Musa J, Achenbach C, Taiwo B, Berzins B, Silas O, Daru PH, Agbaji O, Imade G, Sagay AS, Idoko JA, Kanki PJ, Murphy RL. High-risk human papilloma virus and cervical abnormalities in HIV-infected women with normal cervical cytology. Infect Agent Cancer. 2014 Nov 3;9(1):36. eCollection 2014. PMID: 25395987; PMCID: PMC4230523.
  13. Okonkwo P, Sagay AS, Agaba PA, Yohanna S, Agbaji OO, Imade GE, Banigbe B, Adeola J, Oyebode TA, Idoko JA, Kanki PJ. Treatment outcomes in a decentralized antiretroviral therapy program: a comparison of two levels of care in north central Nigeria. AIDS Res Treat. 2014;2014:560623. Epub 2014 Jun 17. PMID: 25028610; PMCID: PMC4083764.
  14. Imade GE, Sagay AS, Chaplin B, Chebu P, Musa J, Okpokwu J, Hamel DJ, Pam IC, Agbaji O, Samuels J, Meloni S, Sankalé JL, Okonkwo P, Kanki P. Short communication: Transmitted HIV drug resistance in antiretroviral-naive pregnant women in north central Nigeria. AIDS Res Hum Retroviruses. 2014 Feb;30(2):127-33. Epub 2013 Nov 22.   PMID: 24164431; PMCID: PMC3910445.
  15. Kanki PJ, Rowland-Jones S. The protective effect of HIV-2 infection: implications for understanding HIV-1 immunity. AIDS. 2014 Apr 24;28(7):1065-7. PMID: 24685743.
  16. Ebonyi AO, Oguche S, Ejeliogu EU, Okpe ES, Agbaji OO, Sagay AS, Okonkwo P, Idoko JA, Kanki P. Risk factors for first-line antiretroviral treatment failure in HIV-1 infected children attending Jos University Teaching Hospital, Jos, North Central Nigeria. British Journal of Medical Research. 2014; 4(15):2983-2994.
  17. Olaleye DO, Odaibo GN, Carney P, Agbaji O, Sagay AS, Muktar H, Akinyinka OO, Omigbodun AO, Ogunniyi A, Gashau W, Akanmu S, Ogunsola F, Chukwuka C, Okonkwo PI, Meloni ST, Adewole I, Kanki PJ, Murphy RL. Enhancement of health research capacity in Nigeria through north-south and in-country partnerships. Acad Med. 2014 Aug;89(8 Suppl):S93-7. PMID: 25072590.
  18. Agaba PA, Meloni ST, Sule HM, Agbaji OO, Ekeh PN, Job GC, Nyango N, Ugoagwu PO, Imade GE, Idoko JA, Kanki PJ. Patients who present late to HIV care and associated risk factors in Nigeria. HIV Med. 2014 Aug;15(7):396-405. Epub 2014 Jan 20. PMID: 24580742.
  19. Meloni ST, Chang C, Chaplin B, Rawizza H, Jolayemi O, Banigbe B, Okonkwo P, Kanki P. Time-Dependent Predictors of Loss to Follow-Up in a Large HIV Treatment Cohort in Nigeria. Open Forum Infect Dis. 2014 Aug 6;1(2):ofu055. eCollection 2014 Sep. PMID: 25734125; PMCID: PMC4281819.
  20. Kuti MA, Adesina OA, Awolude OA, Ogunbosi BO, Fayemiwo SA, Akinyemi JO, Adetunji AA, Irabor AE, Odaibo GN, Prosper O, Taiwo BO, Olaleye D, Murphy RL, Kanki P, Adewole IF. Dyslipidemia in ART-Naive HIV-Infected Persons in Nigeria-Implications for Care. J Int Assoc Provid AIDS Care. 2014 Oct 20. [Epub ahead of print]   PMID: 25331224.
  21. Chaplin B, Meloni S, Eisen G, Jolayemi T, Banigbe B, Adeola J, Wen C, Reyes Nieva H, Chang C, Okonkwo P, Kanki P. Scale-up of networked HIV treatment in Nigeria: creation of an integrated electronic medical records system. Int J Med Inform. 2015 Jan;84(1):58-68. Epub 2014 Sep 30. PMID: 25301692.
  22. Abah IO, Darin KM, Ebonyi AO, Ugoagwu P, Ojeh VB, Nasir N, Falang KD, Olaitan O, Agbaji O, Idoko J, Kanki P. Patterns and Predictors of First-Line Antiretroviral Therapy Modification in HIV-1-Infected Adults in a Large Urban Outpatient Cohort in Nigeria. J Int Assoc Provid AIDS Care. 2015 Jan 7. [Epub ahead of print] PMID: 25566781.
  23. Balogun M, Sekoni A, Meloni ST, Odukoya O, Onajole A, Longe-Peters O, Ogunsola F, Kanki PJ. Trained Community Volunteers Improve Tuberculosis Knowledge and Attitudes Among Adults in a Periurban Community in Southwest Nigeria. Am J Trop Med Hyg. 2015 Mar 4;92(3):625-632. Epub 2014 Dec 15. PMID: 25510722.